Close

McNicoll Lewis & Vlak Starts Sunesis Pharmaceuticals (SNSS) at Buy; Vosaroxin in Pivotal Phase III AML Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. MSFT


Go back to McNicoll Lewis & Vlak Starts Sunesis Pharmaceuticals (SNSS) at Buy; Vosaroxin in Pivotal Phase III AML Trial
SUNESIS PHARMA (NASDAQ: SNSS) Delayed: 5.32 --0 (-0%)
Previous Close $5.32    52 Week High $5.00 
Open $0.43    52 Week Low $0.44 
Day High $5.32    P/E N/A 
Day Low $5.32    EPS $-0.60 
Volume 94,317